– Feeding practices · infants at risk for, or having early symptoms consistent with, opioid withdrawal
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
– Support of the mother‐infant dyad · infants at risk for, or having early symptoms consistent with, opioid withdrawal
1 finding from 1 review
Admission to NICU (primary outcome)№ of participants: 204(1 RCT) · infants at risk for, or having early symptoms consistent with, opioid withdrawal
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Prolonged abstinence at longest · smokers with COPD
Pharmacological treatment leads to higher prolonged abstinence at longest compared with placebo (high certainty).
5 findings from 1 review
RR 2.53 [1.83, 3.5]
4 studies · 1429 participants
High
RR 2.6 [1.29, 5.24]
1 study · 370 participants
High
RR 2.03 [1.26, 3.28]
2 studies · 503 participants
Moderate
Show 2 more findings
Depression symptoms ‐ short term · health problem or population
1 finding from 1 review
Depression remission · health problem or population
Summary of findings table ‐ Pharmacological treatment probably leads to higher depression remission ‐ short term compared with placebo (moderate certainty).
1 finding from 1 review
All‐cause mortality ‐ short term · health problem or population
It is very uncertain whether summary of findings table ‐ Pharmacological treatment changes all‐cause mortality ‐ short term compared with placebo (very low certainty).
1 finding from 1 review
Myocardial infarction (0 to 30 days) · health problem or population
It is very uncertain whether summary of findings table ‐ Pharmacological treatment changes myocardial infarction ‐ short term compared with placebo (very low certainty).
1 finding from 1 review
Withdrawal symptoms · management of opium withdrawal
4 findings from 1 review
Show 1 more finding
no estimate extracted
34 participants
Very low
Change in rate of amputation (2 months) (Difference in number of amputations at start of treatment) · patients with Buerger's disease
1 finding from 1 review
Days' pharmacological treatment · newborn infants with opioid withdrawal
1 finding from 1 review
Days' pharmacological treatment · newborn infants with opioid withdrawal
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Days' pharmacological treatment · newborn infants with opioid withdrawal
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Days' pharmacological treatment · newborn infants with opioid withdrawal
1 finding from 1 review
Days' pharmacological treatment · newborn infants with opioid withdrawal
1 finding from 1 review
Days' pharmacological treatment · newborn infants with opioid withdrawal
1 finding from 1 review
Intervention not reported
Fatigue severity at the end of pharmacological treatment (assessed by different fatigue scales) · people with stroke with fatigue
It is very uncertain whether the intervention changes fatigue severity at the end of pharmacological treatment (assessed… (very low certainty).
1 finding from 1 review
Intervention not reported
Fatigue severity at the end of non‐pharmacological treatment (assessed by different fatigue scales) · people with stroke with fatigue
It is very uncertain whether the intervention changes fatigue severity at the end of non‐pharmacological treatment… (very low certainty).
1 finding from 1 review
use of opiate during treatment ( · patients with opioid detoxification
Any Psychosocial plus any Pharmacological probably leads to lower use of opiate during the treatment objective compared with any Pharmachological alone compared to (moderate certainty).
1 finding from 1 review
Depression: meeting study criteria for depression at end of · people with depression after stroke
1 finding from 1 review